Establishing Normative Data for Pupillometer Assessments in Neuro-Intensive Care (ENDPANIC)
Sponsor: NeurOptics Inc.
Listed as NCT02804438, this observational or N/A phase trial focuses on Critical Illness and Neuropathy and remains actively recruiting participants. Sponsored by NeurOptics Inc., it has been updated 17 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
17 versions recorded-
Nov 2025 — Present [monthly]
Recruiting
-
Nov 2024 — Nov 2025 [monthly]
Recruiting
-
Sep 2024 — Nov 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jan 2024 — Jul 2024 [monthly]
Recruiting
▶ Show 12 earlier versions
-
Jan 2023 — Jan 2024 [monthly]
Recruiting
-
Sep 2022 — Jan 2023 [monthly]
Recruiting
-
Sep 2021 — Sep 2022 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Sep 2020 — Jan 2021 [monthly]
Recruiting
-
Jun 2020 — Sep 2020 [monthly]
Recruiting
-
Oct 2019 — Jun 2020 [monthly]
Recruiting
-
Sep 2018 — Oct 2019 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Jul 2018 — Sep 2018 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Jul 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Jul 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- NeurOptics Inc.
- University of Texas Southwestern Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .